Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.30% | 5.02% | 4.93% | 10.09% | 2.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.30% | 5.02% | 4.93% | 10.09% | 2.70% |
| Cost of Revenue | 3.56% | 6.23% | 2.84% | 0.16% | -3.02% |
| Gross Profit | 7.40% | 4.52% | 5.77% | 14.36% | 5.17% |
| SG&A Expenses | 3.80% | 7.44% | 4.40% | 9.04% | 2.92% |
| Depreciation & Amortization | 10.19% | 10.27% | 3.91% | 1.99% | 0.54% |
| Other Operating Expenses | -- | -- | -- | -- | -43.00% |
| Total Operating Expenses | 3.55% | 7.20% | 4.23% | 5.00% | 0.46% |
| Operating Income | 16.23% | -4.34% | 7.95% | 35.60% | 11.66% |
| Income Before Tax | 480.35% | 23.48% | 38.70% | 183.40% | 10.85% |
| Income Tax Expenses | -344.04% | 439.76% | 47.03% | 93.21% | 289.73% |
| Earnings from Continuing Operations | 422.35% | -16.12% | 36.23% | 217.90% | -138.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -66.67% | 0.00% | 33.33% | 0.00% | -200.00% |
| Net Income | 421.23% | -16.13% | 36.37% | 1,537.32% | -55.36% |
| EBIT | 16.23% | -4.34% | 7.95% | 35.60% | 11.66% |
| EBITDA | 12.32% | -0.71% | 5.54% | 18.89% | 6.23% |
| EPS Basic | 424.18% | -15.78% | 37.02% | 1,535.20% | -54.69% |
| Normalized Basic EPS | 90.12% | -9.82% | 6.44% | 84.58% | -29.66% |
| EPS Diluted | 422.35% | -16.30% | 36.99% | 1,534.76% | -54.69% |
| Normalized Diluted EPS | 89.49% | -10.08% | 6.14% | 84.48% | -29.66% |
| Average Basic Shares Outstanding | -0.91% | -0.43% | -0.48% | 0.10% | 0.43% |
| Average Diluted Shares Outstanding | -0.57% | -0.14% | -0.19% | 0.14% | 0.43% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.31% | 0.19% | -0.27% | -0.94% | 0.35% |